
Selling, general and administrative expenses from continuing for the third quarter of 2018 were $12.5 million, compared to $12.2 million in the prior year period. The increase in SG&A expenses for this period was primarily attributable to planned investments in our globalgo-to-market teams and product development organization.
Consolidated net income from continuing operations for the third quarter of 2018 was $2.6 million, or $0.11 per basic and diluted share, compared to net income of $0.7million, or $0.05 per basic and diluted share, for the same period in 2017.
Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) from continuing operations for the third quarter of 2018 was $6.4 million, or 14.9% of revenue, compared to Adjusted EBITDA of $6.4 million, or 15.1% of revenue, in the third quarter of 2017. Schedule 3 attached to this press release provides a reconciliation of net loss to each of EBIT (Earnings Before Interest and Taxes), EBITDA and Adjusted EBITDA.
Consolidated Results from Continuing Operations for the Nine Months Ended September 30, 2018
Consolidated revenue from continuing operations for the nine months ended September 30, 2018 was $122.1 million, compared to $114.5 million for the same period last year, an increase of 6.6%. For the nine months ended September 30, 2018, revenue from the Recovery Audit Services segments was $117.3 million compared to $111.1 million in the prior year, and from the Adjacent Services segment was $4.8 million compared to $3.5 million in 2017. On a constant dollar basis adjusted for changes in foreign exchange rates, consolidated revenue from continuing operations increased by 5.8% in the nine months ended September 30, 2018, compared to the same period in the prior year. On a constant dollar basis, revenue from the Recovery Audit Services segments increased 4.8% and revenue from the Adjacent Services segment increased 36.9% for the for the nine months ended September 30, 2018 compared to the same period in 2017.
Total cost of revenue from continuing operations for the nine months ended September 30, 2018 was $78.3 million, or 64.1% of revenue, compared to $75.3 million, or 65.7% of revenue, in the same period last year, an improvement of approximately 160 basis points in gross margin as a percentage of revenue.
SG&A expenses from continuing operations for the nine months ended September 30, 2018 were $36.6 million, compared to $34.1 million in the prior year period. The increase in SG&A expenses for this period was primarily attributable to planned investments in our product development organization and globalgo-to-market team.
Consolidated net loss from continuing operations for the nine months ended September 30, 2018 was $2.6 million, or a negative $0.12 per basic and diluted share, compared to a net loss of $1.1 million, or a negative $0.05 per basic and diluted share, for the same period in 2017.